Mangoceuticals shares soar 49.24% after Nuclea unit signs Utah nuclear MOU
The after-hours jump followed an agreement tied to Mangoceuticals' planned merger with Nuclea Energy, which is seeking a Nasdaq listing while developing its Morpheus microreactor.